DNTH earnings: a positive outcome, +7.1%

On March 8, 2022, Dianthus Therapeutics, Inc. /DE/ reached its earnings. The result was a positive outcome, and the stock moved +7.1% in the window around the event. It had already run -15.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.